15/05/2025
An agreement for technical cooperation has been signed between Nepal’s Kantipur Pharmaceuticals Lab Limited (KPL) and South Korea’s KBNP Incorporated. A special ceremony was organized in the capital on Wednesday, where representatives from both companies signed the agreement.
From KPL, Chairman Hemraj Badal, and from KBNP, CEO Hanee Swang, signed the agreement in the presence of Narayan Prasad Dhakal, Director-General of the Department of Drug Administration.